HCPCS Codes (Alphanumeric, CPT AMA) ICD-9-CM Codes Covered by Medicare Program

Transcription

1 HCPCS s (Alphanumeric, CPT AMA) Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening ICD-9-CM s Covered by Medicare Program The individual ICD-9-CM codes included in code ranges in the table below can be viewed on CMS website under Downloads: Lab List. The link is: :// Salmonella gastroenteritis Salmonella septicemia Shigellosis , , , Other food poisoning (bacterial) Amebiasis Other protozoal intestinal diseases Intestinal infections due to other specified bacteria Ill-defined intestinal infections Tuberculosis of intestines, peritoneum, and mesenteric glands Whipple s disease Syphilitic peritonitis Syphilis of liver Gonococcal infection, acute, lower genitourinary tract Gonococcal Infection anus and rectum Gonococcal endocaritis Other cestode infection 124 Trichinosis Other intestinal helminthiases Late effects of other and unspecified infectious and parasitic diseases Malignant neoplasm of digestive organisms Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum Kaposi s sarcoma, gastrointestinal sites Secondary malignant neoplasm of intestines Secondary malignant neoplasm of other digestive organs & spleen Disseminated malignant neoplasm Acute lymphoid leukemia, without mention of having achieved Fu Associates, Ltd. 145 January 2013

2 Acute lymphoid leukemia, in relapse Chronic lymphoid leukemia, without mention of having achieved Chronic lymphoid leukemia, in relapse Subacute lymphoid leukemia, without mention of having achieved Subacute lymphoid leukemia, in relapse Other lymphoid leukemia, without mention of having achieved Other lymphoid leukemia, in relapse Unspecified lymphoid leukemia, without mention of having achieved Unspecified lymphoid leukemia, in relapse Acute myeloid leukemia, without mention of having achieved Acute myeloid leukemia, in relapse Chronic myeloid leukemia, without mention of having achieved Chronic myeloid leukemia, in relapse Subacute myeloid leukemia, without mention of having achieved Subacute myeloid leukemia, in relapse Myeloid sarcoma, without mention of having achieved remission and in remission Myeloid sarcoma, in relapse Other myeloid leukemia, without mention of having achieved Other myeloid leukemia, in relapse Unspecified myeloid leukemia, without mention of having achieved Unspecified myeloid leukemia, in relapse Acute monocytic leukemia, without mention of having achieved Acute monocytic leukemia, in relapse Chronic monocytic leukemia, without mention of having achieved Chronic monocytic leukemia, in relapse Subacute monocytic leukemia, without mention of having achieved Subacute monocytic leukemia, in relapse Other monocytic leukemia, without mention of having achieved Other monocytic leukemia, in relapse Fu Associates, Ltd. 146 January 2013

3 Unspecified monocytic leukemia, without mention of having achieved Unspecified monocytic leukemia, in relapse Acute erythremia and erythroleukemia, without mention of having achieved Acute erythremia and erythroleukemia, in relapse Chronic erythremia, without mention of having achieved remission and in remission Chronic erythremia, in relapse Megakaryocytic leukemia, without mention of having achieved Megakaryocytic leukemia, in relapse Other specified leukemia, without mention of having achieved Other specified leukemia, in relapse Acute leukemia of unspecified cell type, without mention of having achieved Acute leukemia of unspecified cell type, in relapse Chronic leukemia of unspecified cell type, without mention of having achieved Chronic leukemia of unspecified cell type, in relapse Subacute leukemia of unspecified cell type, without mention of having achieved Subacute leukemia of unspecified cell type, in relapse Other leukemia of unspecified cell type, without mention of having achieved Other leukemia of unspecified cell type, in relapse Unspecified leukemia of unspecified cell type, without mention of having achieved Unspecified leukemia of unspecified cell type, in relapse Malignant carcinoid tumors of the small intestine Malignant carcinoid tumors of the appendix, large intestine & rectum Benign carcinoid tumors of the small intestine Benign carcinoid tumors of the appendix, large intestine and rectum Secondary neuroendocrine tumor, unspecified site Secondary neuroendocrine tumor of distant lymph nodes Secondary neuroendocrine tumor of liver Secondary neuroendocrine tumor of bone Secondary neuroendocrine tumor of peritoneum Secondary Merkel cell carcinoma Secondary neuroendocrine tumor of other sites Benign neoplasm of other parts of digestive system Fu Associates, Ltd. 147 January 2013

4 Hemangioma of intra-abdominal structures Carcinoma in situ of digestive organs Neoplasm of uncertain behavior of stomach, intestines, and rectum Neoplasm of uncertain behavior of other & unspecified digestive organs Neoplasm of unspecified nature, digestive system Iron deficiency anemias Myelophthisis Siderblastic anemia and anemia of other chronic disease Antineoplastic chemotherapy induced anemia Other and unspecified anemias Coagulation defects Allergic purpura; qualitative platelet defects; other nonthrombocytopenic purpuras; primary thrombocytopenia Posttransfusion purpura Other secondary thrombocytopenia Thrombocytopenia, unspecified; other specified and unspecified hemorrhagic conditions Neoplasm related pain (acute) (chronic) Hereditary hemorrhagic telangiectasia Hemorrhoids Esophageal varices with or without mention of bleeding , , , Diseases of the esophagus Gastric ulcer; duodenal ulcer; peptic ulcer, site unspecified; gastrojejunal ulcer; and gastritis and duodenitis Eosinophilic gastritis, without mention of obstruction Eosinophilic gastritis, with obstruction Persistent vomiting Dyspepsia and other specified and unspecified functional disorders of stomach Other disorders of stomach and duodenum Angiodysplasia of stomach and duodenum Dieulafoy lesion (hemorrhagic) of stomach and duodenum Other specified disorders of stomach and duodenum Non-infectious enteritis and colitis Eosinophilic gastroenteritis Eosinophilic colitis Non-infectious enteritis and colitis Intestinal obstruction: intussusceptions, paralytic ileus, volvulus Impaction of intestine, unspecified Gallstone ileus Fu Associates, Ltd. 148 January 2013

5 Fecal impaction Other impaction of intestine Diverticulosis/diverticulitis of colon Functional digestive disorders, not elsewhere classified Anal fissure and fistula Anal and rectal polyp Rectal prolapse Hemorrhage of rectum and anus , Other specified disorders of rectum and anus Ulceration and perforation of intestine Angiodysplasia of intestine with or without mention of hemorrhage Dieulafoy lesion (hemorrhagic) of intestine Vomiting of fecal matter Chronic liver disease and cirrhosis Diseases of the pancreas Gastrointestinal hemorrhage Celiac disease Other specified intestinal malabsorption Intestinovesical fistula Endometriosis of intestine Chronic fatigue syndrome Functional quadriplegia Other malaise and fatigue Anorexia Abnormal loss of weight Nausea and vomiting Bilious emesis Heartburn Dysphagia, unspecified Dysphagia, oral phase Dysphagia, oropharyngeal phase Dysphagia, pharyngeal phase Dysphagia, pharyngo-esophageal phase Other dysphagia Abnormal feces Diarrhea Other symptoms involving digestive system Abdominal pain Abdominal or pelvic swelling, mass, or lump Abdominal rigidity Malignant ascites Fu Associates, Ltd. 149 January 2013

6 Other ascites Abdominal tenderness Colic Abnormal coagulation profile Nonspecific abnormal findings in stool contents Nonspecific (abnormal) findings on radiological and other examination, abdominal area, including retroperitoneum Nonspecific abnormal results of function studies, liver Injury to gastrointestinal tract , Injury to gastrointestinal tract Injury to liver without mention of open wound into cavity Injury to liver with open wound into cavity Injury to kidney without mention of open wound into cavity Injury to kidney with open wound into cavity Injury to blood vessels of abdomen and pelvis Crushing injury of trunk, other specified sites Crushing injury of trunk, multiple sites Crushing injury of trunk, unspecified site Poisoning by agents primarily affecting blood constituents, anticoagulants Unspecified adverse effect of unspecified drug, medicinal and biological substance Failed moderate sedation during procedure V10.00-V10.09 Personal history of malignant neoplasm, gastrointestinal tract V12.00 Personal history of unspecified infectious and parasitic disease V12.72 Personal history of colonic polyps V58.61 Long term (current) use of anticoagulants V58.63-V58.65 Long-term (current) drug use V58.66 Long-term (current) use of aspirin V58.69 Long term (current) use of other medications V67.51 Following treatment w/ high risk medication, not elsewhere specified Indications 1. To evaluate known or suspected alimentary tract conditions that might cause bleeding into the intestinal tract. 2. To evaluate unexpected anemia. 3. To evaluate abnormal signs, symptoms, or complaints that might be associated with loss of blood. 4. To evaluate patient complaints of black or red-tinged stools. Fu Associates, Ltd. 150 January 2013